I now have comprehensive, authoritative textbook content. Let me compile the full answer.
Magnesium-Calcium Correlation
Magnesium (Mg²⁺) and calcium (Ca²⁺) are closely interrelated at multiple levels - physiologically, hormonally, at the renal tubule, and in clinical disease states. Here is a systematic breakdown:
1. Parallel Roles in Cellular Biology
Both are divalent cations that participate in:
- Neuromuscular excitability - deficiency of either causes tetany, muscle cramps, and CNS hyperexcitability
- Enzyme function - magnesium is a cofactor for hundreds of enzymatic reactions; calcium drives exocytosis and coagulation
- Bone mineralization - 99% of body calcium and ~60% of body magnesium are stored in the skeleton
The body contains ~1000 mmol of magnesium (distributed similarly to potassium, mainly intracellular), while calcium (~1200 g total) is primarily in bone. Both share the property that serum levels are a poor reflection of total body stores. - Pye's Surgical Handicraft, p. 1507-1527
2. The PTH Axis - Key Hormonal Link
PTH (parathyroid hormone) is regulated by both Ca²⁺ and Mg²⁺:
- The calcium-sensing receptor (CaSR) on parathyroid cells monitors extracellular Ca²⁺ and Mg²⁺
- Hypocalcemia → stimulates PTH secretion → raises serum Ca²⁺ (via bone resorption, renal Ca²⁺ retention, and intestinal Ca²⁺ absorption via calcitriol)
- Hypomagnesemia → also stimulates PTH secretion (parallel, though less potent effect)
- Hypermagnesemia → inhibits PTH secretion, just as hypercalcemia does - Costanzo Physiology 7th Ed., p. 696
Critical exception - Severe/Chronic Hypomagnesemia:
- When Mg²⁺ depletion is severe (e.g., alcoholism, chronic malnutrition), the relationship reverses: severe hypomagnesemia inhibits PTH synthesis, storage, and secretion by the parathyroid glands - Costanzo Physiology 7th Ed., p. 696
3. Hypomagnesemia Causes Hypocalcemia (Two Mechanisms)
This is the most clinically important Mg-Ca correlation:
Mechanism 1 - Impaired PTH secretion:
At very low serum Mg (<0.4 mmol/L, i.e., <0.8 meq/L, <1 mg/dL), defects in PTH secretion occur. The parathyroids cannot respond normally to low calcium.
Mechanism 2 - PTH resistance (peripheral):
Even when some PTH is secreted, target organs (bone, kidney) become resistant to its action when magnesium is severely depleted. This is a PTH-independent mechanism of hypocalcemia.
The result is hypocalcemia that cannot be corrected by calcium supplementation alone - magnesium must be repleted first. Both abnormalities reverse with magnesium therapy. - Harrison's Principles of Internal Medicine 22E, p. 752; Frameworks for Internal Medicine, p. 6837; Brenner & Rector's The Kidney, p. 2899
4. Shared Renal Handling
Ca²⁺ and Mg²⁺ are reabsorbed at similar nephron segments and share common regulatory machinery:
| Nephron Segment | Ca²⁺ Reabsorption | Mg²⁺ Reabsorption |
|---|
| Proximal tubule | ~65% | ~20-30% |
| Thick ascending limb (TAL) of Henle | ~20% (paracellular) | ~60-70% (paracellular) |
| Distal tubule (DCT) | ~10-15% (active, TRPV5) | ~10% (active, TRPM6) |
- PTH enhances both Ca²⁺ and Mg²⁺ reabsorption in the TAL (via claudin-14 inhibition) and DCT
- Claudin-16 and claudin-19 in the TAL mediate paracellular reabsorption of BOTH Ca²⁺ and Mg²⁺ - mutations cause simultaneous hypomagnesemia + hypercalciuria
- Claudin-10b mutations cause hypermagnesemia + other electrolyte shifts - Brenner & Rector's The Kidney, p. 2248-2258
Key shared triggers for renal wasting of both:
- Loop diuretics (furosemide) - inhibit Na-K-2Cl transporter in TAL, impairing paracellular Ca²⁺ and Mg²⁺ reabsorption
- Hypercalcemia, ECF volume expansion, severe phosphate depletion - all impair Mg²⁺ reabsorption
- Drugs: cisplatin, aminoglycosides, cyclosporine, cetuximab - cause renal Mg²⁺ wasting - Harrison's, p. 746
5. The Calcium-Sensing Receptor (CaSR) - Shared Sensor
The CaSR is activated by both Ca²⁺ and Mg²⁺. Activating mutations of CaSR cause:
- Hypocalcemia (reduced PTH secretion)
- Hypomagnesemia (about 50% of cases)
- Hypercalciuria
- Polyuria
This syndrome can mimic primary hypoparathyroidism. - Brenner & Rector's The Kidney, p. 2050
6. Genetic/Hereditary Syndromes Linking Both
| Syndrome | Mg²⁺ | Ca²⁺ |
|---|
| Gitelman syndrome (SLC12A3 mutation) | Low (Mg wasting) | Low-normal (hypocalciuria) |
| Bartter syndrome | Low | Variable |
| Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (claudin-16/19 mutations) | Low | High urine Ca²⁺, nephrocalcinosis |
| Activating CaSR mutations | Low | Low |
| Autosomal dominant renal hypomagnesemia with hypocalciuria (Na-K-ATPase γ-subunit) | Low | Low urinary Ca²⁺ |
7. Clinical Implications - "Refractory Hypokalemia and Hypocalcemia"
Hypomagnesemia frequently coexists with hypokalemia and hypocalcemia. The rule:
Always check and replete Mg²⁺ first when Ca²⁺ or K⁺ fails to correct with supplementation alone.
This is because Mg²⁺ is required for PTH secretion, PTH end-organ action, and for the proper function of Na-K-ATPase (which maintains K⁺ balance). - Harrison's 22E, p. 752
8. Digoxin Toxicity - Shared Potentiator
Both hypomagnesemia and hypercalcemia enhance sensitivity to digoxin toxicity (along with hypokalemia). This is a practical bedside correlation: before giving digoxin, or in suspected digoxin toxicity, check all three. - Tietz Textbook of Laboratory Medicine, 7th Ed.
Summary Table
| Feature | Mg²⁺ | Ca²⁺ | Correlation |
|---|
| PTH regulation | Stimulates PTH secretion (mild-mod deficiency) | Primary driver of PTH secretion | Parallel, Mg is secondary |
| PTH action | Required for PTH effect on bone/kidney | Target of PTH | Mg deficiency → PTH resistance |
| CaSR sensing | Sensed by CaSR | Primary ligand of CaSR | Shared receptor |
| Renal TAL reabsorption | Claudin-16/19, PTH | Claudin-16/19, PTH | Same paracellular pathway |
| Serum deficiency symptom | Tetany, seizures, arrhythmia | Tetany, seizures, QT prolongation | Near-identical neuromuscular features |
| Severe deficiency → other ion | Causes hypocalcemia | Severe hypocalcemia can impair Mg handling | One-directional in severe disease |